BOSTON — In the staging of liver fibrosis in the post-liver transplant setting, readings from noninvasive tests commonly have major discrepancies when compared with liver biopsy results, particularly ...
Please provide your email address to receive an email when new articles are posted on . Noninvasive tests for liver fibrosis screening performed worse among Black adults vs. other racial-ethnic groups ...
An intelligent liver function test platform (iLFT) successfully integrated into one Scottish primary care system reduced unnecessary specialist referrals over a 5-year period, and improved triage for ...
An AI-powered blood test that analyzes DNA fragments could detect silent liver disease long before symptoms begin.
The BMP8A Fibrosis Score (BFS) offers improved accuracy over existing noninvasive scoring systems for identifying advanced liver fibrosis in MASH patients. BFS eliminates grey-zone results, providing ...
Abstract presenting 48-week IMPACT Phase 2b efficacy and safety data selected for inclusion in “Best of EASL 2026” by EASLOral presentation will ...
Please provide your email address to receive an email when new articles are posted on . A recent analysis found that factors like age, BMI and diabetes status did not significantly affect improvements ...
As the prevalence of liver disease continues to climb alongside diabetes and obesity, the role of the primary care physician is evolving from referral maker to frontline manager.
A combination of silybin and carvedilol is more effective than either drug alone for treating liver fibrosis, found a new study published in Targetome. Liver fibrosis is a chronic and multifactorial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results